N
NeuroLogica
Designs, engineers, manufactures and markets medical imaging equipment for healthcare facilities and private practice
About NeuroLogica
NeuroLogica, a subsidiary of Samsung Electronics, operates at the forefront of medical imaging, specializing in the design, manufacturing, and distribution of point-of-care computed tomography (CT) scanners. The company was established in 2004 in the Boston area by co-founder Dr. Bernard Gordon, a prolific inventor often regarded as the "father of analog to digital conversion" for his contributions to medical tomography and other high-precision instrumentation. The founding vision was inspired by a personal need to make imaging solutions more accessible, which led to the development of a prototype mobile CT scanner.
A significant milestone occurred in January 2013 when Samsung Electronics America acquired NeuroLogica, integrating it into its Health and Medical Equipment division. This acquisition was a strategic move for Samsung to expand its medical imaging business and leverage its global brand with NeuroLogica's specialized technology. The company's business model revolves around the direct sale of its advanced medical imaging equipment to healthcare facilities, including hospitals and private practices, worldwide. Its client base spans various departments such as intensive care units, neurosurgical operating rooms, emergency rooms, and mobile stroke units.
NeuroLogica's product line features a range of portable CT scanners designed to bring imaging directly to the patient. The CereTom®, launched in 2005, was the world's first portable head and neck CT scanner. This was followed by the BodyTom® in 2011, a full-body, 32-slice mobile CT scanner, now available with 64-slice capability. A key feature of the BodyTom is its large 85cm bore and internal lead shielding, which allows it to be used in various rooms without extensive build-outs. The OmniTom Elite®, released in 2017, is a 16-slice head and neck scanner that can perform non-contrast CT, CT angiography, and CT perfusion scans at the point of care. In 2022, NeuroLogica received FDA clearance for the OmniTom® Elite with a Photon Counting Detector (PCD), which aims to improve image quality and reduce radiation dosage.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2004
- Headquarters
- Danvers, United States
- Employees
- 242
- Open positions
- 8
- Dealroom signal
- 62.9/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Facility Management, Patient Care, Hard Tech, DT and LS, science-based
- Technology
- Artificial Intelligence, Big Data, Deep Tech, Computer Vision
- Business model
- Manufacturing
- Client focus
- B2B
News
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jan 2013 | $0 | — | Samsung Electronics | — |
| EARLY VC✓Equity / VC | Jan 2012 | $12M | $48M | Undisclosed | — |
Growth signals
Latest recorded traffic for NeuroLogica is 1.7K monthly website visits, down 77.9% over the last three months. NeuroLogica's team declined 30.3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
NeuroLogica in the Danvers ecosystem
The NeuroLogica office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors1 additional known investor
Samsung Electronics
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about NeuroLogica on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NeuroLogica’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








